Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study

Although prolonged-release tacrolimus (PR-T) is widely approved for posttransplantation immunosuppression in kidney recipients, large-scale studies are required to assess long-term outcomes. We present follow-up data from the Advagraf-based Immunosuppression Regimen Examining New Onset Diabetes Mell...

Descripción completa

Detalles Bibliográficos
Autores principales: Pernin, Vincent, Glyda, Maciej, Viklický, Ondrej, Lõhmus, Aleksander, Wennberg, Lars, Witzke, Oliver, von Zur-Mühlen, Bengt, Anaokar, Swapneel, Hurst, Martin, Kazeem, Gbenga, Undre, Nasrullah, Kuypers, Dirk R.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977488/
https://www.ncbi.nlm.nih.gov/pubmed/36875940
http://dx.doi.org/10.1097/TXD.0000000000001432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977488/
https://www.ncbi.nlm.nih.gov/pubmed/36875940
http://dx.doi.org/10.1097/TXD.0000000000001432

Ejemplares similares